References
- Baehni P, Tsai CC, McArthur WP, Hammond BF, Taichman NS. Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived gram-negative microorganism. Infect Immun 1979;24:233-243.
- Brandes A, Moller-Hartmann W, Giannitsis E, Diederich KW. Focal meningoencephalitis as initial manifestation of Actinomyces actinomycetemcomitans endocarditis. Med Klin (Munich) 1993;88:88-90.
- Helgeland K, Nordby O. Cell cycle-specific growth inhibitory effect on human gingival fibroblasts of a toxin isolated from the culture medium of Actinomyces actinomycetemcomitans. J Periodontal Res 1993;28:161-165. https://doi.org/10.1111/j.1600-0765.1993.tb01064.x
- Nakano K, Inaba H, Nomura R et al. Detection and serotype distribution of Aggregatibacter actinomycetemcomitans in cardiovascular specimens from Japanese patients. Oral Microbiol Immunol 2007;22:136-139. https://doi.org/10.1111/j.1399-302X.2007.00332.x
- Paturel L, Casalta JP, Habib G, Nezri M, Raoult D. Actinomyces actinomycetemcomitans endocarditis. Clin Microbiol Infect 2004;10:98-118. https://doi.org/10.1111/j.1469-0691.2004.00794.x
- Shenker BJ, Vitale LA, Welham DA. Immune suppression induced by Actinomyces actinomycetemcomitans: effects on immunoglobulin production by human B cells. Infect Immun 1990;58:3856-3862.
- Slots J, Reynolds HS, Genco RJ. Actinomyces actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect Immun 1980;29:1013-1020.
- Sugai M, Kawamoto T, Peres SY et al. The cell cycle-specific growth-inhibitory factor produced by Actinomyces actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998;66:5008-5019.
- Fives-Taylor P, Meyer D, Mintz K. Characteristics of Actinomyces actinomycetemcomitans invasion of and adhesion to cultured epithelial cells. Adv Dent Res 1995;9:55-62. https://doi.org/10.1177/08959374950090011001
- Shenker BJ, Kushner ME, Tsai CC. Inhibition of fibroblast proliferation by Actinomyces actinomycetemcomitans. Infect Immun 1982;38:986-992.
- Shenker BJ, McKay T, Datar S et al. Actinomyces actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol 1999;162:4773-4780.
- Lara-Tejero M, Galan JE. Cytolethal distending toxin: limited damage as a strategy to modulate cellular functions. Trends Microbiol 2002;10:147-152. https://doi.org/10.1016/S0966-842X(02)02316-8
- Nesic D, Hsu Y, Stebbins CE. Assembly and function of a bacterial genotoxin. Nature 2004;429:429-433. https://doi.org/10.1038/nature02532
- Nishikubo S, Ohara M, Ueno Y et al. An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem 2003;278:50671-50681. https://doi.org/10.1074/jbc.M305062200
- Avenaud P, Castroviejo M, Claret S et al. Expression and activity of the cytolethal distending toxin of Helicobacter hepaticus. Biochem Biophys Res Commun 2004;318:739-745. https://doi.org/10.1016/j.bbrc.2004.04.089
- Elwell CA, Dreyfus LA. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 2000;37:952-963. https://doi.org/10.1046/j.1365-2958.2000.02070.x
- Love JD, Hewitt RR. The relationship between human serum and human pancreatic DNase I. J Biol Chem 1979;254:12588-12594.
- Saiki K, Konishi K, Gomi T, Nishihara T, Yoshikawa M. Reconstitution and purification of cytolethal distending toxin of Actinomyces actinomycetemcomitans. Microbiol Immunol 2001;45:497-506. https://doi.org/10.1111/j.1348-0421.2001.tb02650.x
- Middelberg AP. Preparative protein refolding. Trends Biotechnol 2002;20:437-443. https://doi.org/10.1016/S0167-7799(02)02047-4
- Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 2005;99: 303-310. https://doi.org/10.1263/jbb.99.303
- Shenker BJ, Besack D, McKay T et al. Actinomyces actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC. J Immunol 2004;172:410-417. https://doi.org/10.4049/jimmunol.172.1.410
- Wising C, Svensson LA, Ahmed HJ et al. Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model. Microb Pathog 2002;33: 49-62. https://doi.org/10.1006/mpat.2002.0516
- Akifusa S, Poole S, Lewthwaite J, Henderson B, Nair SP. Recombinant Actinomyces actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun 2001;69:5925-5930. https://doi.org/10.1128/IAI.69.9.5925-5930.2001
- Shenker BJ, Hoffmaster RH, Zekavat A et al. Induction of apoptosis in human T cells by Actinomyces actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle. J Immunol 2001;167:435-441. https://doi.org/10.4049/jimmunol.167.1.435
- Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 1994;62:244-251.
- Evans SJ, Shipstone EJ, Maughan WN, Connolly BA. Site-directed mutagenesis of phosphate-contacting amino acids of bovine pancreatic deoxyribonuclease I. Biochemistry 1999;38:3902-3909. https://doi.org/10.1021/bi9824893
- Suck D. DNA recognition by DNase I. J Mol Recognit 1994;7:65-70. https://doi.org/10.1002/jmr.300070203